New drug aims to free patients from steroid dependence

NCT ID NCT07156175

Summary

This study is testing an investigational drug called SAR444336 to see if it can help adults with microscopic colitis stay in remission without needing to keep taking steroid medication. Participants must already be in remission while taking budesonide. The main goal is to see if the new drug can help them stay well for 24 weeks after stopping steroids.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MICROSCOPIC COLITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • A.O.U. Città della Salute e della Scienza di Torino, Presidio Molinette, S.C. Gastroenterologia U., Investigational Site Number : 380002

    RECRUITING

    Turin, Torino, 10126, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Azienda Ospedale Università Padova, Investigational Site Number : 380001

    RECRUITING

    Padua, Padova, 35128, Italy

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, Investigational Site Number : 380004

    RECRUITING

    Milan, Milano, 20122, Italy

    Contact Email: •••••@•••••

    Contact

  • Fondazione Policlinico Gemelli IRCCS Roma, Investigational Site Number : 380003

    RECRUITING

    Rome, Roma, 00168, Italy

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Investigational Site Number : 0560001

    RECRUITING

    Leuven, 3000, Belgium

  • Investigational Site Number : 0560002

    RECRUITING

    Ghent, 9000, Belgium

  • Investigational Site Number : 2080002

    RECRUITING

    Hvidovre, 2650, Denmark

  • Investigational Site Number : 2080003

    RECRUITING

    Aarhus, 8200, Denmark

  • Investigational Site Number : 2500001

    RECRUITING

    Créteil, 94010, France

  • Investigational Site Number : 2500002

    RECRUITING

    Montfermeil, 93370, France

  • Investigational Site Number : 2500003

    RECRUITING

    Pessac, 33604, France

  • Investigational Site Number : 2760001

    RECRUITING

    Frankfurt, 60389, Germany

  • Investigational Site Number : 2760002

    RECRUITING

    Potsdam, 14467, Germany

  • Investigational Site Number : 2760003

    RECRUITING

    Tübingen, 72076, Germany

  • Investigational Site Number : 2760004

    RECRUITING

    Ulm, 89081, Germany

  • Investigational Site Number : 2760005

    RECRUITING

    Ludwigshafen, 67067, Germany

  • Investigational Site Number : 3480002

    RECRUITING

    Budapest, 1085, Hungary

  • Investigational Site Number : 3480003

    RECRUITING

    Székesfehérvár, 8000, Hungary

  • Investigational Site Number : 6160002

    RECRUITING

    Warsaw, Masovian Voivodeship, 02-507, Poland

  • Investigational Site Number : 6160003

    RECRUITING

    Warsaw, Masovian Voivodeship, 00-728, Poland

  • Investigational Site Number : 6160004

    RECRUITING

    Bydgoszcz, Kuyavian-Pomeranian Voivodeship, 85-229, Poland

  • Investigational Site Number : 7520001

    RECRUITING

    Linköping, 581 85, Sweden

  • Investigational Site Number : 7520002

    RECRUITING

    Stockholm, 113 61, Sweden

  • Investigational Site Number : 7520003

    RECRUITING

    Stockholm, 116 91, Sweden

  • Investigational Site Number : 8260001

    RECRUITING

    Oxford, Oxfordshire, OX3 9DU, United Kingdom

  • Investigational Site Number : 8260002

    RECRUITING

    Cambridge, Cambridgeshire, CB2 2QQ, United Kingdom

Conditions

Explore the condition pages connected to this study.